Richard A. Slayden
Affiliations: | Cell and Molecular Biology (Graduate Degree Program) | Colorado State University, Fort Collins, CO |
Area:
Microbiology Biology, Pathology, Molecular BiologyGoogle:
"Richard Slayden"Children
Sign in to add trainee| Kathleen E. Brostrom | grad student | 2009 | Colorado State |
| Luke C. Kingry | grad student | 2011 | Colorado State |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Slayden RA, Dawson CC, Cummings JE. (2018) Toxin-antitoxin systems and regulatory mechanisms in Mycobacterium tuberculosis. Pathogens and Disease. 76 |
| Cummings JE, Slayden RA. (2017) Transient In Vivo Resistance Mechanisms of Burkholderia pseudomallei to Ceftazidime and Molecular Markers for Monitoring Treatment Response. Plos Neglected Tropical Diseases. 11: e0005209 |
| Knudson SE, Cummings JE, Bommineni GR, et al. (2016) Formulation studies of InhA inhibitors and combination therapy to improve efficacy against Mycobacterium tuberculosis. Tuberculosis (Edinburgh, Scotland). 101: 8-14 |
| Wang K, Langevin S, O'Hern CS, et al. (2016) Anomaly Detection in Host Signaling Pathways for the Early Prognosis of Acute Infection. Plos One. 11: e0160919 |
| Thanna S, Knudson SE, Grzegorzewicz A, et al. (2016) Synthesis and evaluation of new 2-aminothiophenes against Mycobacterium tuberculosis. Organic & Biomolecular Chemistry |
| Bommineni GR, Kapilashrami K, Cummings JE, et al. (2016) Thiolactomycin-based inhibitors of bacterial β-ketoacyl-ACP synthases with in vivo activity. Journal of Medicinal Chemistry |
| Knudson SE, Awasthi D, Kumar K, et al. (2015) Cell division inhibitors with efficacy equivalent to isoniazid in the acute murine Mycobacterium tuberculosis infection model. The Journal of Antimicrobial Chemotherapy |
| Knudson SE, Kumar K, Awasthi D, et al. (2014) In vitro-in vivo activity relationship of substituted benzimidazole cell division inhibitors with activity against Mycobacterium tuberculosis. Tuberculosis (Edinburgh, Scotland). 94: 271-6 |
| Schiebel J, Chang A, Shah S, et al. (2014) Rational design of broad spectrum antibacterial activity based on a clinically relevant enoyl-acyl carrier protein (ACP) reductase inhibitor. The Journal of Biological Chemistry. 289: 15987-6005 |
| Knudson SE, Awasthi D, Kumar K, et al. (2014) A trisubstituted benzimidazole cell division inhibitor with efficacy against Mycobacterium tuberculosis. Plos One. 9: e93953 |